The investigation conducted implies additional therapeutic capabilities of using CP in treating glioblastomas, and an example of such new capability is the synergistic action of CP and complex composite DNA-based preparation within the frames of the currently reported Karanahan approach. This evidence concerns the gene CP and glioblastoma.